OpenAI has become the lead investor in Merge Labs, a new brain-computer interface research lab co-founded by Sam Altman that just raised around $250 million USD in seed funding Merge Labs is ...

An important milestone has been achieved in brain-computer interface (BCI) technology. A new peer-reviewed study published in Nature Biomedical Engineering shows how a high-performance brain-computer ...

O. Rose Broderick reports on the health policies and technologies that govern people with disabilities’ lives. Before coming to STAT, she worked at WNYC’s Radiolab and Scientific American, and her ...

Access to high school computer science courses has plateaued, and overall high school student participation in those classes has declined slightly, concludes Code.org’s annual report on the state of ...

JAKARTA, Indonesia (AP) — A zoo on Java island released photos of Indonesia's first locally-born giant panda cub, and said the male cub was showing signs of being in good health. The mother, ...

Forbes contributors publish independent expert analyses and insights. Solange Charas covers the intersection of governance, HR, and finance. As neural interfaces move from labs to enterprise, boards ...

In September 2024, California quietly set a precedent. Lawmakers passed SB 1223, an amendment to the California Consumer Privacy Act (CCPA) that classifies neural ...

Civilians have run for safety after Indonesia's Semeru volcano erupted on Wednesday, sending a 54,000ft cloud of ash into the air. Residents have been put on high alert on the island and urged to keep ...

While companies like Elon Musk’s Neuralink are hard at work on brain-computer interfaces that require surgery to cut open the skull and insert a complex array of wires into a person’s head, a team of ...

JAKARTA, Indonesia (AP) — Landslides triggered by torrential rains in Indonesia ’s Java island killed two people and left 21 others missing, officials said Friday. Rescuers are still searching for the ...

Neuropsychiatric disorders, such as depression and ADHD, remain a global health burden, with current treatments often limited by individual variability and insufficient long-term efficacy. In a ...